Trump executive order backs change to Medicare negotiation pushed by drug industry

A new executive order signed Tuesday by President Trump directs Congress to change a key provision of the law allowing Medicare drug price negotiations, a move that would fix one of the drug industry’s biggest complaints. The order applies to what the industry calls the Inflation Reduction Act’s “pill penalty,” where small molecule drugs—typically pills—face Medicare...